Auxly Cannabis Group Stock Number Of Shares Shorted
| 3KF Stock | EUR 0.02 0 10.00% |
Auxly Cannabis Group fundamentals help investors to digest information that contributes to Auxly Cannabis' financial success or failures. It also enables traders to predict the movement of Auxly Stock. The fundamental analysis module provides a way to measure Auxly Cannabis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Auxly Cannabis stock.
Auxly |
Auxly Cannabis Group Company Number Of Shares Shorted Analysis
Auxly Cannabis' Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
| Competition |
Based on the recorded statements, Auxly Cannabis Group has 0.0 of outstending shares currently sold short by investors. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Drug Manufacturers - Specialty & Generic industry. The number of shares shorted for all Germany stocks is 100.0% higher than that of the company.
Did you try this?
Run Transaction History Now
Transaction HistoryView history of all your transactions and understand their impact on performance |
| All Next | Launch Module |
Auxly Fundamentals
| Return On Equity | -35.01 | |||
| Return On Asset | -9.93 | |||
| Current Valuation | 321.75 M | |||
| Shares Outstanding | 565 M | |||
| Price To Earning | 20.65 X | |||
| Price To Book | 1.15 X | |||
| Price To Sales | 328.84 X | |||
| Revenue | 1.51 M | |||
| Gross Profit | 6.47 M | |||
| EBITDA | (12.93 M) | |||
| Net Income | (20.6 M) | |||
| Cash And Equivalents | 156.23 M | |||
| Cash Per Share | 0.37 X | |||
| Total Debt | 68.94 M | |||
| Debt To Equity | 29.30 % | |||
| Current Ratio | 9.36 X | |||
| Book Value Per Share | 0.49 X | |||
| Cash Flow From Operations | (13.7 M) | |||
| Earnings Per Share | (0.07) X | |||
| Beta | 7.93 | |||
| Market Capitalization | 347.95 M | |||
| Z Score | 3.0 |
About Auxly Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Auxly Cannabis Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Auxly Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Auxly Cannabis Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Auxly Stock
Auxly Cannabis financial ratios help investors to determine whether Auxly Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Auxly with respect to the benefits of owning Auxly Cannabis security.